| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |